The Board of Directors in Bio-Works Technologies AB has made the decision to send out a business update on a quarterly basis, beginning with the fourth quarter 2025. We will be reporting net sales, the orderbook and the order intake for the last quarter directly after the closing of the quarter.
The business update will give owners and investors information more quickly and give a better understanding of the company's development.
Bio-Works Technologies Business Update fourth quarter 2025
Net Sales: MSEK Compare
Fourth quarter 2025 23,7 (2,6)
Last two quarters 40,4 (12,5)
Last four quarters 62,5 (25,5)
Order intake: MSEK Compare
Fourth quarter 2025 25,6 (6,1)
Order-book on 2025-12-31 32,5
Amounts on net sales and orders in table above are preliminary numbers.
Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Arne Hauge, CFO, e-mail: arne.hauge@bio-works.com, phone: +46(0)8-502 705 83.
About Bio-Works
Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development.
Bio-Works' headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For more information, visit www.bio-works.com.